Evidence map›Paper›PMID 32551115›Full record

ArticleSAGE open medical case reports2020

Dissolution of metastatic thymic carcinoma-associated right atrial thrombus with rivaroxaban.

Curlene Nimblette, Rajeev Seecheran, Jessica Kawall, Valmiki Seecheran, Sangeeta Persad, Koomatie Ramsaroop, Naveen Anand Seecheran

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in SAGE open medical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Curlene NimbletteNorth Central Regional Health Authority, Mt. Hope, Trinidad and Tobago.
Rajeev SeecheranNorth Central Regional Health Authority, Mt. Hope, Trinidad and Tobago.
Jessica KawallNorth Central Regional Health Authority, Mt. Hope, Trinidad and Tobago.
Valmiki SeecheranNorth Central Regional Health Authority, Mt. Hope, Trinidad and Tobago.
Sangeeta PersadNorth Central Regional Health Authority, Mt. Hope, Trinidad and Tobago.
Koomatie RamsaroopNorth Central Regional Health Authority, Mt. Hope, Trinidad and Tobago.
Naveen Anand SeecheranDepartment of Clinical Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago.ORCID https://orcid.org/0000-0002-7779-0181
University of the West Indies · TT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thymic carcinoma typically exhibits more clinically aggressive behavior and portends a worse prognosis as compared to thymoma. Venous thromboembolism is a significant cause of morbidity and mortality in oncologic patients. Traditionally, the standard-of-care management of cancer-associated venous thromboembolism has been therapeutic anticoagulation with low molecular weight heparins; however, with the advent of direct oral anticoagulants, there is an ongoing paradigm shift to transition to these novel agents in an attempt to attenuate cancer-associated venous thromboembolism events. We describe an exceedingly rare case of metastatic thymic carcinoma-associated right atrial thrombus with high-risk embolic features, which subsequently underwent near-complete dissolution with rivaroxaban after 3 months.

Indexed as

direct oral anticoagulationrivaroxabanthrombusThymic carcinomathymoma

Identifiers

PMID32551115
PMCPMC7278298
OpenAlexW3033430584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.